The Role of Recurrent Psychosocial Stressors as a Trigger for Relapse in Paranoid Schizophrenia: A Case Study
Abstract
Introduction: Schizophrenia is a chronic mental disorder that can be understood through the diathesis–stress model, in which biological vulnerability interacts with environmental stressors to trigger illness onset and relapse. Psychosocial stressors, including interpersonal conflict and failure to achieve significant life goals, are recognized as important precipitants of relapse. This case report aims to illustrate the role of recurrent psychosocial stressors in triggering relapse in a patient with paranoid schizophrenia. Methods: This study employed a descriptive case report design. Data were obtained through direct anamnesis, physical examination, and psychiatric status examination of a 28-year-old male patient who presented to the Psychiatric Outpatient Clinic of Jemursari Islamic Hospital, Surabaya, on October 8, 2025. The case was analyzed using the diathesis–stress model to explain the mechanism of relapse. Results: The patient was diagnosed with Paranoid Schizophrenia in Incomplete Remission (Axis I) and Emotionally Unstable Personality Disorder, Borderline Type (Axis II). He had longstanding vulnerabilities, including chronic family conflict since childhood and substance use beginning in adolescence. Relapse of psychotic symptoms in 2021 was precipitated by a major psychosocial stressor—failure in a highly valued career selection process. This event triggered emotional decompensation, a depressive episode, and relapse into substance use as a maladaptive coping strategy, ultimately leading to the re-emergence of paranoid delusions and auditory hallucinations. This case demonstrates that relapse represents a multifactorial process resulting from the interaction between pre-existing vulnerability and acute psychosocial stressors. Conclusion: Psychosocial stressors play a critical role in triggering relapse in individuals vulnerable to schizophrenia. Effective management should extend beyond pharmacotherapy to include psychosocial interventions focused on stress management and the development of adaptive coping strategies to reduce relapse risk and improve long-term outcomes.

